Clinical Trial Update: TAME: A Pilot Study of Weekly Paclitaxel, Bevacizumab, and Tumor Associated Macrophage Targeted Therapy (Zoledronic Acid) in Women With Recurrent, Platinum-resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 pilot trial (EARLY_PHASE1) assessing weekly paclitaxel, bevacizumab, and zoledronic acid in women with recurrent platinum-resistant epithelial ovarian…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Peritoneal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Taxol (paclitaxel)
• Zometa (Zoledronic acid)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Epithelial Ovarian, Fallopian Tube | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING